Analyze Diet
Journal of veterinary internal medicine2021; 35(5); 2486-2494; doi: 10.1111/jvim.16221

Gentamicin-induced sensorineural auditory loss in healthy adult horses.

Abstract: Irreversible sensorineural auditory loss has been reported in humans treated with aminoglycosides but not in horses. Objective: Investigate if auditory loss occurs in horses treated using the recommended IV daily dosage of gentamicin for 7 consecutive days. Methods: Ten healthy adult horses (7-15 years; females and males, 5 each). Methods: Prospective study. Physical and neurological examinations and renal function tests were performed. Gentamicin sulfate was administered at a dosage of 6.6 mg/kg via the jugular vein on alternating sides for 7 days. Gentamicin peak and trough concentrations were measured. Horses were sedated using detomidine hydrochloride IV to perform brainstem auditory evoked responses (BAER) before the first dose, immediately after the last dose, and 30 days after the last dose. Peaks latencies, amplitudes, and amplitude ratios were recorded. Data from the second and last BAER were compared to results at baseline. Bone conduction was performed to rule out conduction disorders. Results: Seven horses had auditory loss: complete bilateral (N = 1), complete unilateral (N = 2), and partial unilateral (N = 4). Based on physical examination and BAER results, sensorineural auditory loss was suspected. Absent bone conduction ruled out a conduction disorder and further supported sensorineural auditory loss in horses with completely absent BAER. Auditory dysfunction was reversible in 4 of 7 horses. Conclusions: Gentamicin at recommended doses may cause sensorineural auditory loss in horses that might be irreversible. Follow-up studies are needed to investigate if other dosing protocols present a similar risk.
Publication Date: 2021-07-28 PubMed ID: 34322916PubMed Central: PMC8478042DOI: 10.1111/jvim.16221Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study investigates whether gentamicin, an antibiotic treatment, could cause hearing loss in healthy adult horses. It was found that this drug could indeed result in sensorineural auditory loss, which may be irreversible in some cases.

Study Design

  • The study involved ten healthy adult horses, both female and male, aging between 7 to 15 years.
  • This research was prospective in nature meaning that the subjects were chosen and then observed over a certain time period.
  • Various tests, including physical and neurological examinations and renal function tests, were performed to track the health and progress of the horses.
  • Gentamicin sulfate was given to the horses through the jugular vein alternate side for a week.
  • After the dosage, gentamicin peak and trough concentrations were also measured.

Methodology

  • All ten horses were subjected to brainstem auditory evoked responses (BAER) before the first dose, immediately after the last dose, and 30 days post dose. This test measures the electrical activity in the auditory nerve, auditory pathways, and in the brain that occur in response to clicks.
  • Any changes in peaks latencies, amplitudes, and amplitude ratios were recorded and compared to baseline data.
  • Bone conduction was additionally used to rule out any conduction disorders.

Results

  • Out of the ten horses in the study, seven were found to have auditory loss. This varied in degree with one horse having complete bilateral auditory loss, two with complete unilateral loss and four with partial unilateral loss.
  • Physical examination and BAER results led to a suspicion of sensorineural auditory loss, which was further confirmed by absent bone conduction.
  • Auditory dysfunction was reversible in four out of the seven horses. However, in three cases, this seemed be irreversible.

Conclusion

  • The study concludes that gentamicin at recommended doses could potentially result in irreversible sensorineural auditory loss in horses. The researchers acknowledge the need for further studies to explore if other dosage protocols also pose a similar risk to horses.

Cite This Article

APA
Aleman MR, True A, Scalco R, Crowe CM, Costa LRR, Chigerwe M. (2021). Gentamicin-induced sensorineural auditory loss in healthy adult horses. J Vet Intern Med, 35(5), 2486-2494. https://doi.org/10.1111/jvim.16221

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 35
Issue: 5
Pages: 2486-2494

Researcher Affiliations

Aleman, Monica R
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, USA.
True, Alexander
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, USA.
Scalco, Rebeca
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, USA.
Crowe, Chelsea M
  • William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, California, USA.
Costa, Lais R R
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, USA.
Chigerwe, Munashe
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, USA.

MeSH Terms

  • Animals
  • Anti-Bacterial Agents / adverse effects
  • Evoked Potentials, Auditory, Brain Stem
  • Female
  • Follow-Up Studies
  • Gentamicins / adverse effects
  • Horses
  • Male
  • Prospective Studies

Grant Funding

  • V435622 / Equine and Comparative Neurology Research Group

Conflict of Interest Statement

Munashe Chigerwe serves as Associate Editor for the Journal of Veterinary Internal Medicine. He was not involved in review of this manuscript. No other authors have a conflict of interest.

References

This article includes 56 references
  1. Aleman M, Holliday TA, Nieto JE, Williams DC. Brainstem auditory evoked responses in an equine patient population: part I--adult horses.. J Vet Intern Med 2014 Jul-Aug;28(4):1310-7.
    pmc: PMC4857955pubmed: 24902479doi: 10.1111/jvim.12379google scholar: lookup
  2. Aleman M, Madigan JE, Williams DC, Holliday TA. Brainstem auditory evoked responses in an equine patient population. Part II: foals.. J Vet Intern Med 2014 Jul-Aug;28(4):1318-24.
    pmc: PMC4857935pubmed: 24903742doi: 10.1111/jvim.12377google scholar: lookup
  3. Aleman M, Spriet M, Williams DC, Nieto JE. Neurologic Deficits Including Auditory Loss and Recovery of Function in Horses with Temporohyoid Osteoarthropathy.. J Vet Intern Med 2016 Jan-Feb;30(1):282-8.
    pmc: PMC4913646pubmed: 26513722doi: 10.1111/jvim.13654google scholar: lookup
  4. Tanner J, Spriet M, Espinosa-Mur P, Estell KE, Aleman M. The prevalence of temporal bone fractures is high in horses with severe temporohyoid osteoarthropathy.. Vet Radiol Ultrasound 2019 Mar;60(2):159-166.
    pubmed: 30461109doi: 10.1111/vru.12702google scholar: lookup
  5. Wilson WJ, Mills PC, Dzulkarnain AA. Use of BAER to identify loss of auditory function in older horses.. Aust Vet J 2011 Mar;89(3):73-6.
  6. Magdesian KG, Williams DC, Aleman M, Lecouteur RA, Madigan JE. Evaluation of deafness in American Paint Horses by phenotype, brainstem auditory-evoked responses, and endothelin receptor B genotype.. J Am Vet Med Assoc 2009 Nov 15;235(10):1204-11.
    pubmed: 19912043doi: 10.2460/javma.235.10.1204google scholar: lookup
  7. Nostrandt AC, Pedersoli WM, Marshall AE, Ravis WR, Robertson BT. Ototoxic potential of gentamicin in ponies.. Am J Vet Res 1991 Mar;52(3):494-8.
    pubmed: 2035927
  8. Durham AE. An evaluation of serum gentamicin concentrations and bacterial susceptibility to gentamicin in equine practice.. J Vet Intern Med 2018 May;32(3):1194-1201.
    pmc: PMC5980452pubmed: 29575239doi: 10.1111/jvim.15078google scholar: lookup
  9. Magdesian KG, Hogan PM, Cohen ND, Brumbaugh GW, Bernard WV. Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses.. J Am Vet Med Assoc 1998 Oct 1;213(7):1007-11.
    pubmed: 9776999
  10. Dowling PM. Aminoglycosides and aminocyclitols. In: Giguere S, Prescott JF, Dowling PM, eds. Anitimicrobial Therapy in Veterinary Medicine. 5th ed.Ames, IA: Wiley Blackwell; 2013:233‐255.
  11. Arroyo MG, Slovis NM, Moore GE, Taylor SD. Factors Associated with Survival in 97 Horses with Septic Pleuropneumonia.. J Vet Intern Med 2017 May;31(3):894-900.
    pmc: PMC5435057pubmed: 28271546doi: 10.1111/jvim.14679google scholar: lookup
  12. Dacre KJP, Pirie S, Prince DP. Choke, pleuropneumonia and suspected gentamicin vestibulotoxicity in a horse. Equine Vet Educ 2003;15:27‐33.
  13. Newton SA, Knottenbelt DC. Vestibular disease in two horses: a case of mycotic otitis media and a case of temporohyoid osteoarthropathy.. Vet Rec 1999 Jul 31;145(5):142-4.
    pubmed: 10466833doi: 10.1136/vr.145.5.142google scholar: lookup
  14. Toth B, Aleman M, Nogradi N, Madigan JE. Meningitis and meningoencephalomyelitis in horses: 28 cases (1985-2010).. J Am Vet Med Assoc 2012 Mar 1;240(5):580-7.
    pubmed: 22332628doi: 10.2460/javma.240.5.580google scholar: lookup
  15. Feary DJ, Magdesian KG, Aleman MA, Rhodes DM. Traumatic brain injury in horses: 34 cases (1994-2004).. J Am Vet Med Assoc 2007 Jul 15;231(2):259-66.
    pubmed: 17630894doi: 10.2460/javma.231.2.259google scholar: lookup
  16. Bedenice D, Hoffman AM, Parrott B, McDonnel J. Vestibular signs associated with suspected lightning strike in two horses.. Vet Rec 2001 Oct 27;149(17):519-22.
    pubmed: 11708637doi: 10.1136/vr.149.17.519google scholar: lookup
  17. Johnstone LK, Mayhew IG, Fletcher LR. Clinical expression of lolitrem B (perennial ryegrass) intoxication in horses.. Equine Vet J 2012 May;44(3):304-9.
  18. Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Parfitt R, Ciarimboli G. Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.. Clin Pharmacol Ther 2017 Apr;101(4):491-500.
    pubmed: 28002638doi: 10.1002/cpt.603google scholar: lookup
  19. Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.. Int J Otolaryngol 2011;2011:937861.
    pmc: PMC3202092pubmed: 22121370doi: 10.1155/2011/937861google scholar: lookup
  20. Strain GM, Merchant SR, Neer TM, Tedford BL. Ototoxicity assessment of a gentamicin sulfate otic preparation in dogs.. Am J Vet Res 1995 Apr;56(4):532-8.
    pubmed: 7785834
  21. Clark CH. Toxicity of aminoglycoside antibiotics.. Mod Vet Pract 1977 Jul;58(7):594-8.
    pubmed: 329097
  22. Blanke A, Aupperle H, Seeger J, Kubick C, Schusser GF. Histological study of the external, middle and inner ear of horses.. Anat Histol Embryol 2015 Dec;44(6):401-9.
    doi: 10.1111/ahe.12151:1-9pubmed: 25283481google scholar: lookup
  23. Oishi N, Talaska AE, Schacht J. Ototoxicity in dogs and cats.. Vet Clin North Am Small Anim Pract 2012 Nov;42(6):1259-71.
    pmc: PMC3490132pubmed: 23122180doi: 10.1016/j.cvsm.2012.08.005google scholar: lookup
  24. Barabas K, Milner R, Lurie D, Adin C. Cisplatin: a review of toxicities and therapeutic applications.. Vet Comp Oncol 2008 Mar;6(1):1-18.
  25. Mayhew IG, Preston SE, Hannant D, Washbourne JR, Johnson CB, Phillips TJ. Spontaneous otoacoustic emission in a pony.. Vet Rec 1995 Apr 22;136(16):419.
    pubmed: 7625060doi: 10.1136/vr.136.16.419google scholar: lookup
  26. Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: An Overview.. Cold Spring Harb Perspect Med 2016 Jun 1;6(6).
    pmc: PMC4888811pubmed: 27252397doi: 10.1101/cshperspect.a027029google scholar: lookup
  27. Bauquier JR, Boston RC, Sweeney RW, Wilkins PA, Nolen-Walston RD. Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin.. J Vet Intern Med 2015 Nov-Dec;29(6):1660-6.
    pmc: PMC4895685pubmed: 26426540doi: 10.1111/jvim.13626google scholar: lookup
  28. Spehlmann R. The normal BAEP. Evoked Potential Primer. Stoneham, MA: Butterworth Publishers; 1985:204‐216.
  29. Spehlmann R. The abnormal BAEP. Evoked Potential Primer. Stoneham, MA: Butterworth Publishers; 1985:217‐235.
  30. Seo YJ, Kwak C, Kim S, Park YA, Park KH, Han W. Update on Bone-Conduction Auditory Brainstem Responses: A Review.. J Audiol Otol 2018 Apr;22(2):53-58.
    pmc: PMC5894486pubmed: 29471611doi: 10.7874/jao.2017.00346google scholar: lookup
  31. Schoster A, Amsler M, Kirchgaessner C, Saleh L, Schwarzwald C, Schmitt S. Gentamicin plasma concentrations in hospitalized horses and retrospective minimal inhibitory concentrations of gram-negative equine pathogens.. J Vet Emerg Crit Care (San Antonio) 2021 May;31(3):323-330.
    pubmed: 33274835doi: 10.1111/vec.13035google scholar: lookup
  32. Fee WE Jr. Aminoglycoside ototoxicity in the human.. Laryngoscope 1980 Oct;90(10 Pt 2 Suppl 24):1-19.
  33. Selimoglu E. Aminoglycoside-induced ototoxicity.. Curr Pharm Des 2007;13(1):119-26.
    pubmed: 17266591doi: 10.2174/138161207779313731google scholar: lookup
  34. Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, McDonald WJ. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.. J Infect Dis 1992 Jun;165(6):1026-32.
    pubmed: 1583319doi: 10.1093/infdis/165.6.1026google scholar: lookup
  35. Walling AD, Dickson GM. Hearing loss in older adults.. Am Fam Physician 2012 Jun 15;85(12):1150-6.
    pubmed: 22962895
  36. Strain GM. Forms and mechanisms of deafness. In: Strain GM, ed. Deafness in Dogs and Cats. Oxfordshire: CABI; 2011:40‐52.
  37. Strain GM. The Genetics of Deafness in Domestic Animals.. Front Vet Sci 2015;2:29.
    pmc: PMC4672198pubmed: 26664958doi: 10.3389/fvets.2015.00029google scholar: lookup
  38. Mc Brearty A, Auckburally A, Pollock PJ, Penderis J. Evoked otoacoustic emissions: an alternative test of auditory function in horses.. Equine Vet J 2013 Jan;45(1):60-5.
  39. Siegel JH. Cochlear potentials in the study of cochlear physiology.. Scand Audiol Suppl 1986;25:35-47.
    pubmed: 3554482
  40. Stavroulaki P, Apostolopoulos N, Dinopoulou D, Vossinakis I, Tsakanikos M, Douniadakis D. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.. Int J Pediatr Otorhinolaryngol 1999 Nov 5;50(3):177-84.
    pubmed: 10595663doi: 10.1016/s0165-5876(99)00247-5google scholar: lookup
  41. Theelen MJP, Wilson WD, Byrne BA, Edman JM, Kass PH, Magdesian KG. Initial antimicrobial treatment of foals with sepsis: Do our choices make a difference?. Vet J 2019 Jan;243:74-76.
    pubmed: 30606442doi: 10.1016/j.tvjl.2018.11.012google scholar: lookup
  42. Glass K, Watts AE. Septic Arthritis, Physitis, and Osteomyelitis in Foals.. Vet Clin North Am Equine Pract 2017 Aug;33(2):299-314.
    pubmed: 28687092doi: 10.1016/j.cveq.2017.03.002google scholar: lookup
  43. Estell KE, Young A, Kozikowski T, Swain EA, Byrne BA, Reilly CM, Kass PH, Aleman M. Pneumonia Caused by Klebsiella spp. in 46 Horses.. J Vet Intern Med 2016 Jan-Feb;30(1):314-21.
    pmc: PMC4913652pubmed: 26492860doi: 10.1111/jvim.13653google scholar: lookup
  44. van Altena R, Dijkstra JA, van der Meer ME, Borjas Howard JF, Kosterink JG, van Soolingen D, van der Werf TS, Alffenaar JW. Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.. Antimicrob Agents Chemother 2017 Mar;61(3).
    pmc: PMC5328543pubmed: 28069654doi: 10.1128/aac.01400-16google scholar: lookup
  45. Lanvers-Kaminsky C, Ciarimboli G. Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.. Pharmacogenomics 2017 Dec;18(18):1683-1695.
    pubmed: 29173064doi: 10.2217/pgs-2017-0125google scholar: lookup
  46. Nguyen T, Jeyakumar A. Genetic susceptibility to aminoglycoside ototoxicity.. Int J Pediatr Otorhinolaryngol 2019 May;120:15-19.
    pubmed: 30743189doi: 10.1016/j.ijporl.2019.02.002google scholar: lookup
  47. Hamasaki K, Rando RR. Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness.. Biochemistry 1997 Oct 7;36(40):12323-8.
    pubmed: 9315872doi: 10.1021/bi970962rgoogle scholar: lookup
  48. Hutchin T, Haworth I, Higashi K, Fischel-Ghodsian N, Stoneking M, Saha N, Arnos C, Cortopassi G. A molecular basis for human hypersensitivity to aminoglycoside antibiotics.. Nucleic Acids Res 1993 Sep 11;21(18):4174-9.
    pmc: PMC310046pubmed: 8414970doi: 10.1093/nar/21.18.4174google scholar: lookup
  49. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity.. Pharmacogenomics 2005 Jan;6(1):27-36.
    pubmed: 15723603doi: 10.1517/14622416.6.1.27google scholar: lookup
  50. Wu WJ, Sha SH, Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention.. Audiol Neurootol 2002 May-Jun;7(3):171-4.
    pubmed: 12053140doi: 10.1159/000058305google scholar: lookup
  51. Morovati H, Najafzadeh Varzi H, Avizeh R. Prophylactic effect of silymarin and vitamin E on gentamicin‐induced ototoxicity in dog. Iran J Med Aromatic Plants 2008;24:363‐373.
  52. Balakumar P, Rohilla A, Thangathirupathi A. Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?. Pharmacol Res 2010 Sep;62(3):179-86.
    pubmed: 20434560doi: 10.1016/j.phrs.2010.04.004google scholar: lookup
  53. Wargo KA, Edwards JD. Aminoglycoside-induced nephrotoxicity.. J Pharm Pract 2014 Dec;27(6):573-7.
    pubmed: 25199523doi: 10.1177/0897190014546836google scholar: lookup
  54. Riviere JE, Coppoc GL, Hinsman EJ, Carlton WW, Traver DS. Species dependent gentamicin pharmacokinetics and nephrotoxicity in the young horse.. Fundam Appl Toxicol 1983 Sep-Oct;3(5):448-57.
    pubmed: 6642102doi: 10.1016/s0272-0590(83)80020-7google scholar: lookup
  55. Riviere JE, Hinsman EJ, Coppoc GL, Carlton WW, Traver DS. Morphological and functional aspects of experimental gentamicin nephrotoxicity in young beagles and foals.. Vet Res Commun 1983 Dec;7(1-4):211-3.
    pubmed: 6665986doi: 10.1007/bf02228621google scholar: lookup
  56. van der Harst MR, Bull S, Laffont CM, Klein WR. Gentamicin nephrotoxicity--a comparison of in vitro findings with in vivo experiments in equines.. Vet Res Commun 2005 Apr;29(3):247-61.

Citations

This article has been cited 2 times.
  1. Davies C, Mittal R, Li CY, Marwede H, Bergman J, Hilton N, Mittal J, Bhattacharya SK, Eshraghi AA. Identification of Target Proteins Involved in Cochlear Hair Cell Progenitor Cytotoxicity following Gentamicin Exposure.. J Clin Med 2022 Jul 14;11(14).
    doi: 10.3390/jcm11144072pubmed: 35887836google scholar: lookup
  2. Lai TW, Cheng HL, Su TR, Yang JJ, Su CC. Cichoric Acid May Play a Role in Protecting Hair Cells from Ototoxic Drugs.. Int J Mol Sci 2022 Jun 16;23(12).
    doi: 10.3390/ijms23126701pubmed: 35743144google scholar: lookup